serrawettin w2 has been researched along with Leukemia, Promyelocytic, Acute in 1 studies
*Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, X; Han, T; He, Q; Li, A; Qiu, H; Shen, L; Xiao, Y; Zhang, P | 1 |
1 other study(ies) available for serrawettin w2 and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Genome-driven discovery of new serrawettin W2 analogues from
Topics: Escherichia coli; Humans; Leukemia, Promyelocytic, Acute; Peptides, Cyclic; Serratia | 2023 |